US$ 29.49
tirzepatide no bmi required New drug delivers significant and long-lasting weight loss Who Is a Good Candidate
Description
The honest summary: Retatrutide probably does produce modestly greater weight loss than tirzepatide at maximum doses, potentially in the range of 36 percentage points of body weight

[1] Currently, Mounjaro is the only licensed weight loss treatment available that contains both types of receptor agonist

It just produces worse side effects

Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and cell preservation